These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6886282)

  • 61. [EFFECTS OF NEGATIVE-PRESSURE RESPIRATION ON THE HEMODYNAMICS OF THE GREATER AND LESSER CIRCULATION, ON PULMONARY VENTILATION AND ON DIURESIS IN VAGOTOMIZED ANIMALS AND ANIMALS TREATED WITH HYDERGINE].
    GIUFFRIDA G; CONDORELLI M; FILOCAMO G; MIGLIAU G; PUGLIESE F; BASILE U
    Boll Soc Ital Cardiol; 1964; 9():6-11. PubMed ID: 14134483
    [No Abstract]   [Full Text] [Related]  

  • 62. [Effect of co-dergocrine mesylate on catecholamines and prolactin in elderly hypertensive patients].
    Mies R; Lang R; Weidinger G; Welzel D
    Arzneimittelforschung; 1983; 33(5):771-3. PubMed ID: 6683557
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Dihydroergotoxine mesylate in the treatment of senile cerebral insufficiency. Result of a long-term multicenter double-blind clinical trial with a placebo].
    Lazzari R; Passeri M; Chierichetti SM
    Presse Med; 1983 Dec; 12(48):3179-85. PubMed ID: 6228938
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Experiences with panthesin-hydergine (PH 203) and exacthin (ACTH) in disorders of retinal circulation].
    ORBAN T
    Ophthalmologica; 1960 Dec; 140():388-400. PubMed ID: 13731101
    [No Abstract]   [Full Text] [Related]  

  • 65. [Effect of dihydroergotoxin on myocardial capacitance vessels].
    Ovsiannikov VI
    Biull Eksp Biol Med; 1975 Jul; 80(7):52-4. PubMed ID: 819060
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [USE OF THE ERGOT ALKALOID PREPARATION, HYDERGINE, IN SURGERY].
    WATANUKI T; ISHIZUKA T; MOCHIZUKI N
    Rinsho Geka; 1964 May; 19():694-9. PubMed ID: 14148895
    [No Abstract]   [Full Text] [Related]  

  • 67. The use of PH 203 (panthesine hydergine) in thrombo-embolic diseases in obstetrics and gynaecology.
    GANS B; ECKERLING B; SAX B
    S Afr Med J; 1959 Aug; 33():707-9. PubMed ID: 13826317
    [No Abstract]   [Full Text] [Related]  

  • 68. [Therapy of myocardial infarct in old age with panthesin and hydergine (PH 203)].
    THEINL K
    Wien Med Wochenschr; 1960 Mar; 110():209-12. PubMed ID: 13837684
    [No Abstract]   [Full Text] [Related]  

  • 69. Experimental studies on the action of metabolic and vasoactive substances in the brain.
    Gygax P; Hunziker O; Schulz U; Schweizer A
    Triangle; 1975; 14(2):80-9. PubMed ID: 812223
    [No Abstract]   [Full Text] [Related]  

  • 70. [Preliminary observations on the changes of renal function and blood coagulation processes in normal aged subjects and those with vascular diseases treated with large subintrant doses of hydergine].
    Aradas A
    G Gerontol; 1966 Dec; 14(12):1155-62. PubMed ID: 4966651
    [No Abstract]   [Full Text] [Related]  

  • 71. Helping to make the final years meaningful for the elderly residents of nursing homes.
    Einspruch BC
    Dis Nerv Syst; 1976 Aug; 37(8):439-42. PubMed ID: 821734
    [No Abstract]   [Full Text] [Related]  

  • 72. [CLINICAL STUDY ON AN ERGOT DERIVATIVE: HYDERGINE].
    REBECCHI M; GOTTI A; BENEDETTI L
    Gazz Int Med Chir; 1964 Jan; 68():207-11. PubMed ID: 14154380
    [No Abstract]   [Full Text] [Related]  

  • 73. A double-blind investigation of hydergine in the treatment of cerebrovascular insufficiency in the elderly.
    Rao DB; Norris JR
    Johns Hopkins Med J; 1972 May; 130(5):317-24. PubMed ID: 4622959
    [No Abstract]   [Full Text] [Related]  

  • 74. [Clinical treatment of peripheral arterial occlusive diseases].
    Schulte B
    Fortschr Med; 1976 Sep; 94(27):1500-4. PubMed ID: 823087
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Separation of dihydroergotoxine (hydergine) into dihydroergocornine, dihydroergocryptine and dihydroergocristine by counter-current distribution.
    Galeffi C; Delle Monache EM
    J Chromatogr; 1974 Jan; 88(2):413-5. PubMed ID: 4205319
    [No Abstract]   [Full Text] [Related]  

  • 76. An ergot alkaloid preparation (hydergine) versus placebo for treatment of symptoms of cerebrovascular insufficiency: double-blind study.
    Jennings WG
    J Am Geriatr Soc; 1972 Aug; 20(8):407-12. PubMed ID: 4626496
    [No Abstract]   [Full Text] [Related]  

  • 77. [ANTIEMETIC ACTION OF METOCLOPRAMIDE WITH RESPECT TO APOMORPHINE AND HYDERGINE].
    JUSTIN-BESANCON L; LAVILLE C
    C R Seances Soc Biol Fil; 1964; 158():723-7. PubMed ID: 14186927
    [No Abstract]   [Full Text] [Related]  

  • 78. Validated liquid chromatography-tandem mass spectrometry method for simultaneous determination of clopamide, reserpine and dihydroergotoxine: Application to pharmacokinetics in human plasma.
    Sharaf El-Din MM; Nassar MW; Attia KA; Demellawy MA; Kaddah MM
    J Pharm Biomed Anal; 2016 Jun; 125():236-44. PubMed ID: 27037980
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Short- and long-term treatment of stable effort angina with nicardipine, a new calcium channel blocker: a double-blind, placebo-controlled, randomised, repeated cross-over study.
    Gheorghiade M; St Clair C; St Clair J; Freedman D; Schwemer G
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):195S-205S. PubMed ID: 3927959
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Electroencephalographic alterations after administration of vaso-active substance (Hydergine)].
    Pires de Oliveira RS
    Arq Neuropsiquiatr; 1973 Jun; 31(2):107-22. PubMed ID: 4198581
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.